Vital Signs - Life Sciences and Drug Discovery Technologies Market Consolidation - Unique Aims of Mergers & Acquisitions
Vital Signs - Life Sciences and Drug Discovery Technologies Market Consolidation - Unique Aims of Mergers & Acquisitions
RELEASE DATE
09-Apr-2007
09-Apr-2007
REGION
North America
North America
Research Code: 9561-00-2E-00-00
SKU: HC00478-NA-MR_03950
$1,500.00
In stock
SKU
HC00478-NA-MR_03950
Description
This issue of Vital Signs, released on April 9, 2007, provides a strategic overview of the impact of consolidation in the life sciences and drug discovery technologies market. Additionally, an emerging company profile is provided for Network Biosystems, a developer of DNA analysis technologies for forensics, clinical diagnostics, homeland security, and genomic sequencing applications. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 26 - March 30, 2007.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on April 9, 2007, provides a strategic overview of the impact of consolidation in the life sciences and drug discovery technologies market. Additionally, an emerging company profile is provided for Network Biosystems, a developer of DNA analysis technologies for forensics, clinical diagnostics, homeland security, and genomic sequencing applications. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 26 - March 30, 2007.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-2E-00-00 |
Is Prebook | No |